Influenza A virus A/Brisbane/02/2018 (H1N1) recombinant hemagglutinin antigen Unknown Status Phase 4 Trials for Rheumatoid Arthritis Prevention
Indications | Status | Purpose | Phase |
---|---|---|---|
Unknown Status | Prevention | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01002716 | Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis |